hero-banner-desktop-content-left-align-hero-banner-07-image-n-title

Viral Suppression

Viral Suppression

img-mobile-purple-hero-background

Consistent, sustained viral suppression is the treatment goal1

Viral suppression for long-term success with treatment

Achieving and sustaining viral suppression is paramount for your patients and for reducing HIV transmission in your community.

Scroll down to learn more

People featured are compensated by Gilead.

Adherence to prescribed HIV medication may help patients achieve and maintain viral suppression, which can help reduce the risk of developing drug resistance and help prevent HIV transmission.1

U=U is defined as achieving and maintaining an undetectable viral load for at least 6 months to prevent sexual transmission of HIV to their partners.1

What do the DHHS guidelines say about achieving durable viral suppression?

An easy-to-adhere-to and effective ARV regimen with an appropriate safety and tolerability profile may help achieve sustained virologic suppression1
  • Durable viral suppression improves immune function and confers substantial clinical benefits, lowers the risk of both AIDS-defining and non–AIDS-defining complications, and allows people with HIV to have a life expectancy approaching that of people without HIV
  • The Panel on Antiretroviral Guidelines for Adults and Adolescents recommends initiating ART immediately (or as soon as possible) after HIV diagnosis in order to increase the uptake of ART and linkage to care, decrease the time to viral suppression for individual patients, and improve the rate of virologic suppression among people with HIV
  • To improve and maintain immunologic function and maintain viral suppression, ART should be continued indefinitely without interruption
Predictors of successful virologic suppression1:
  • Low baseline viremia
  • High potency of the antiretroviral regimen
  • Tolerability of the regimen
  • Convenience of the regimen
  • Excellent adherence to the regimen

May cause higher inflammation and immune activation1

May impact adherence, which influences viral suppression1

ART, antiretroviral therapy; ARV, antiretroviral; U=U, undetectable=untransmittable.

Reference:
  1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. US Department of Health and Human Services. Updated September 12, 2024. Accessed January 8, 2025. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf